Business Wire

Attention Business Leaders: These Six Trends Will Impact Your 2019 Digital Transformation Journey

Jaa

Digital moonshots, apps at the edge and information enlightenment will be among the enterprise digital trends to watch in 2019, according to new predictions by DXC Technology (NYSE: DXC), the world’s leading independent, end-to-end IT services company.

The company today laid out six predictions that will define the IT shifts organizations will need to think about to drive their digital strategies next year.

“Business transformation is accelerating as enterprises make big bets on digital strategy to gain operational efficiencies, invent new markets, redesign customer experiences and achieve savings they can reinvest to fund a digital future,” said Dan Hushon, senior vice president and chief technology officer, DXC Technology. “Enterprise leaders should examine how these six trends will shape their digital journey so they can get it right, learn fast and execute forward in 2019.”

Hushon identified six digital trends that will accelerate business transformation in 2019:

1) Enterprises go after digital business moonshots
In 2019, enterprises will make more aligned, bet-the-company execution decisions to accelerate digital business. Expect to see new businesses, business models and technologies built from digital. A unified digital strategy between the business and IT is the only way to unload the compounding technical debt that is holding companies back from exploring moonshot digital initiatives. It’s all about focusing, accelerating digital transformation, having the stamina to succeed and achieving nonlinear growth.

2) Enterprises adopt next-generation IoT platforms
As enterprises map their physical world to an intelligence-rich digital one, smart “things” become a driving force for implementing next-generation platforms in 2019. This advance will enable large quantities of industry-specific data from the internet of things (IoT) to be analyzed, uncovering novel, hyper-dimensional correlations that provide fresh insights, enhanced decision making and better business outcomes.

3) Action at the edge disrupts the cloud
The IT industry continues to build out what we call “the Matrix,” the pervasive, intelligent IT infrastructure that goes beyond cloud to include edge computing, IoT platforms, machine intelligence, augmented reality/virtual reality, blockchain and more. Companies will build completely new ways to leverage the Matrix, including decentralized applications (DApps), shifting power from a small number of central players to a large number of participants. Additionally, a shift toward event-driven applications and serverless architectures allows very small and specific applications to run in lightweight environments such as pocket or wrist devices.

4) Enterprises enter the age of Information Enlightenment
Leveraging information will become a core competency in 2019. Companies that experience Information Enlightenment will realize that artificial intelligence and machine learning can improve service offerings and generate new sources of revenue — but only with the right algorithms, model orchestration, data and infrastructure.

5) Enterprises redesign customer experiences amid stronger data privacy rules
Protecting customers’ personal data will force companies to rethink their digital strategy as the full effects of the General Data Protection Regulation (GDPR) set in. Enterprises must create privacy-centric information ecosystems, with analytics and security as the foundation, as they aim to deliver secure interactions and superior customer experiences.

6) Companies begin closing their data centers
The enterprise data center is becoming less relevant as the data arrival and business processing shift to the cloud. To operate more efficiently and derive more value from their data, enterprises are shifting workloads to public cloud providers, who have massive bandwidth and strategically placed data centers. The trend will play out over the next three to five years, as cloud migration gives way to “built for cloud” replacements.

Resources:

  • DXC Chief Technology Officer Dan Hushon’s 6 digital trends to accelerate business transformation in 2019 article and video
  • DXC’s 6 digital trends for 2019 blog post
  • Follow Dan Hushon at @DanHushon for more on the digital enterprise journey
  • Join the conversation at #DXCDigitalTrends19

About DXC Technology

DXC Technology (NYSE: DXC) is the world’s leading independent, end-to-end IT services company, serving nearly 6,000 private and public-sector clients from a diverse array of industries across 70 countries. The company’s technology independence, global talent and extensive partner network deliver transformative digital offerings and solutions that help clients harness the power of innovation to thrive on change. DXC Technology is recognized among the best corporate citizens globally. For more information, visit dxc.technology.

Contact information

Allison Wilson, Corporate Media Relations
+1.352.502.9539, dwilson215@dxc.com
or
Donna Jenks, Corporate Media Relations
+1.630.306.9989, donna.jenks@dxc.com
or
Jonathan Ford, Investor Relations
+1.703.245.9700, jonathan.ford@dxc.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

AURAK Gains SACSCOC Accreditation15.12.2018 13:49Tiedote

The Southern Association of Colleges and Schools Commission on Colleges (SACSCOC) officially announced the accreditation of the American University of Ras Al Khaimah (AURAK) at its 2018 Annual Meeting which was held in New Orleans, Louisiana, in the United States of America. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181215005017/en/ AURAK delegation during the SACSCOC conference in New Orleans” (Photo: AETOSWire) SACSCOC, the regional body for the accreditation of degree-granting higher education institutions in the Southern United States, has a membership of more than 800 institutions in the Southern states and other international sites approved by SACSCOC that award associate, baccalaureate, master’s, and/or doctoral degrees. SACSCOC also awards accreditation to other international institutions of higher education that satisfy all its requirements and demonstrate compliance with its accreditation standards. AURAK now

Lehman Brothers Treasury Announces Plans for Partial Wind-Down14.12.2018 20:41Tiedote

Lehman Brothers Treasury Co. B.V. in liquidation (“LBT”) today, through its U.S. counsel Kramer Levin Naftalis & Frankel LLP, announced that LBT is planning a final cash distribution to its creditors. Professional holders of eligible notes will have the option to retain their investment by electing to receive substitute notes of one (or a few) series. Such election shall take place through a solicitation process. As a consequence, LBT will be able to reduce the number of series of notes outstanding from more than 3,700 to one or a few. Noteholders electing to receive substitute notes will be afforded the same economic entitlement to distributions received by LBT from Lehman Brothers Holdings Inc. (“LBHI”) through the substitute notes. The substitute notes will be denominated in U.S. dollars and future distributions will be made in U.S. dollars only. Noteholders who are not professional investors, or hold notes that are not eligible for substitution, or do not elect to receive substitut

Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Combination with AVD14.12.2018 20:00Tiedote

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for the extension of the marketing authorization of ADCETRIS (brentuximab vedotin) and recommended its approval in combination with AVD in adult patients with previously untreated CD30+ Stage IV Hodgkin lymphoma. ADCETRIS is an antibody-drug conjugate (ADC) directed at CD30, a defining marker of Hodgkin lymphoma. ADCETRIS is currently not approved as a therapy for previously untreated Hodgkin lymphoma in Europe. “For a large number of previously untreated Hodgkin lymphoma patients diagnosed with Stage IV disease, progression will occur with current treatments, highlighting a true unmet need in this population,” said Anna Sureda, M.D., Ph.D., Head of the Hematology Department and Hematopoietic Stem Cell Transplant Programme, Institut Català d'Oncologia - Hospital Duran i Reynals. “In the ECHELON-1 cl

Diamond CBD, POTN Subsidiary, Enters the $46 Billion Coffee Market With the Release of Premium Line of CBD-Infused Coffee & Tea K-Kup Capsules14.12.2018 18:42Tiedote

Diamond CBD Inc., wholly owned subsidiary of PotNetwork Holdings, Inc. (OTC Pink: POTN), a leader in hemp extraction and innovative CBD products for the wellness market, enters the Coffee segment, an industry expected to reach revenues of $46 Billion in 2018. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181214005308/en/ Experience a cup of Chill (Photo: Business Wire) Produced in accordance with a universal K-Cup design, these pods fit in almost all modern single cup coffee makers, making it an easily integrated enhancement to any environment, delivering 25mgs of CBD in a tasty favorite beverage at less than $5 per cup. This new line of premium Chill Coffee Capsules was recently added to the Company’s broad range of cannabinoid and natural hemp products. Each box comes with 4 individual capsules in original chill coffee, decaf chill coffee, chill black tea, and chill green tea flavors. The unit price for each box is $10.00

Henley & Partners Enlarges Executive Committee to Manage Expansion and Growth14.12.2018 17:00Tiedote

Residence- and citizenship-by-investment programs have firmly established themselves over the past few years as the new frontier in terms of freedom, flexibility, and future-readiness, both for the countries issuing these programs and for the individual investors participating in them. The societal and economic value these programs generate is undisputed. The investment migration industry as a whole is currently grossing roughly USD 18 billion per year, with an expectation that it will hit the USD 20 billion mark very soon. Foreign direct investment (FDI) is now considered the lifeblood of economic growth for many developing and recovering smaller countries around the world. As such, the number of investment migration programs has been increasing rapidly, from just a handful of programs in the 1980s and 1990s to over 100 countries that now have investment migration provisions in their laws. There are more than 60 active programs today, with Moldova and Montenegro — both fast-growing Eu

Vargatef® plus docetaxel could be an option after failure of immunotherapy in lung cancer14.12.2018 12:07Tiedote

Boehringer Ingelheim announced today the first interim results of VARGADO, an ongoing non-interventional study in routine clinical practice in Germany evaluating the efficacy and safety of Vargatef® (nintedanib) and docetaxel in patients with stage III/IV locally advanced or metastatic non-small cell lung cancer (NSCLC) of adenocarcinoma histology. The study consists of three cohorts, two of which allow for prior treatment with immune checkpoint inhibitors (ICIs) either in combination with chemotherapy in the first-line or as monotherapy in the second-line of treatment. The interim results from Cohort B (first-line chemotherapy, second-line immune checkpoint inhibitors, third-line Vargatef® plus docetaxel) were presented today at ESMO Immuno-Oncology Congress 2018 in Geneva.1 Despite a limited sample size, the VARGADO study adds to the body of evidence for nintedanib in lung adenocarcinoma following pre-treatment with chemotherapy and ICIs.1,3 The addition of nintedanib to docetaxel ha

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme